EUVIMEDEUVIMED entdecken
Open Access

Recent advances in oral insulin delivery technologies

Ershuai Zhang, Hui Zhu, Boyi Song, Yuanjie Shi, Zhiqiang Cao

Journal of Controlled Release · 2024-02 · 366 · 221-230

DOI: 10.1016/j.jconrel.2023.12.045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-02. Verfasst von Ershuai Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering and Materials Science, Wayne State University, Detroit, MI, USA. Hauptthemen laut MEDLINE: Gastrointestinal Tract, Insulin. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the rise in diabetes mellitus cases worldwide, oral delivery of insulin is preferred over subcutaneous insulin administration due to its good patient compliance and non-invasiveness, simplicity, and versatility. However, oral insulin delivery is hampered by various gastrointestinal barriers that result in low drug bioavailability and insufficient therapeutic efficiency. Numerous strategies have been developed to overcome these barriers and increase the bioavailability of oral insulin. Yet, no commercial oral insulin product is available to address all clinical hurdles because of various substantial obstacles related to the structural organization and physiological function of the gastrointestinal tract. Herein, we discussed the significant physiological barriers (including chemical, enzymatic, and physical barriers) that hinder the transportation and absorption of orally delivered insulin. Then, we showcased recent significant and innovative advances in oral insulin delivery technologies. Finally, we concluded the review with remarks on future perspectives on oral insulin delivery technologies and potential challenges for forthcoming clinical translation of oral insulin delivery technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal TractInsulinHumansBiological AvailabilityPatient ComplianceTechnology

Stichwörter der Autor:innen

BarriersBioavailabilityDiabetesInsulinOral delivery

Substanzen

Insulin

Autor:innen und Institutionen

  • Department of Chemical Engineering and Materials Science, Wayne State University, Detroit, MI, USA.
  • Department of Chemical Engineering and Materials Science, Wayne State University, Detroit, MI, USA. Electronic address: zcao@wayne.edu.

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health

Zitieren

APA

Zhang, E., Zhu, H., Song, B., Shi, Y., & Cao, Z. (2024). Recent advances in oral insulin delivery technologies. Journal of Controlled Release, 366, 221-230. https://doi.org/10.1016/j.jconrel.2023.12.045

Vancouver

Zhang E, Zhu H, Song B, Shi Y, Cao Z. Recent advances in oral insulin delivery technologies. Journal of Controlled Release. 2024;366:221-230. doi:10.1016/j.jconrel.2023.12.045

BibTeX
@article{Zhang2024,
  author = {Zhang, Ershuai and Zhu, Hui and Song, Boyi and Shi, Yuanjie and Cao, Zhiqiang},
  title = {Recent advances in oral insulin delivery technologies},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {366},
  pages = {221--230},
  doi = {10.1016/j.jconrel.2023.12.045}
}
Kostenlos starten →